Explore. Learn. Join the conversation.

Working Group on New TB Drugs

Stop TB Partnership

7 Jul 2010
by Working Group

Posted in Front Lines of TB R&D, TB News

TB Alliance: New Potential TB Drugs to be Investigated Against Multiple Neglected Diseases

New York, United States and Geneva, Switzerland — July 7, 2010 The TB Alliance and Drugs for Neglected Diseases Initiative (DNDi) announced today a unique first-ever royalty-free license agreement between two not-for-profit drug developers that speeds progress toward markedly improved therapy of multiple neglected diseases.